Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Whole Genome Sequencing Analysis of of SARS-CoV-2 Positive Patients

NCT04353401 is registered in ClinicalTrials.gov with Vanda Pharmaceuticals as lead sponsor.

NCT NCT04353401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04353401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Whole Genome Sequencing Analysis of of SARS-CoV-2 Positive Patients
Lead sponsor
Vanda Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
August 3, 2020
Completion date
March 9, 2022
Enrollment
79 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection, covid-19